Search

everythinglearnresearchcommunity

for

Search:↓

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Anti-androgens are effective for female acne but less so for male-pattern hair loss, with side effects similar to birth control pills.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Hair loss gene linked to prostate issues.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

AKR1C3 could be a treatment target for metabolic issues in PCOS.